Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositis

Arthritis and Rheumatism

Volumn 46, Issue 7, 2002, Pages 1885-1893

  Shamim, Ejaz A ^a,l   Rider, Lisa G ^a   Pandey, Janardan P ^b   O'Hanlon, Terrance P ^a   Jara, Luis J ^c   Samayoa, Eduardo A ^d   Burgos Vargas, Ruben ^e   Vazquez Mellado, Janitzia ^f   Alcocer Varela, Jorge ^g   Salazar Paramo, Mario ^h   Kutzbach, Abraham Garcia ⁱ   Malley, James D ^j   Targoff, Ira N ^k   Garcia De La Torre, Ignacio ^h   Miller, Frederick W ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d Hospital General San Juan de Dios   (Guatemala)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

^g INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^h UNIVERSITY OF GUADALAJARA   (Mexico)

ⁱ Universidad Francisco Marrequin   (Guatemala)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k UNIVERSITY OF OKLAHOMA   (United States)

^l NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN;

ADULT; ALLELE; ALLOTYPE; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE COURSE; ETHNIC GROUP; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MOTIF; QUESTIONNAIRE; RISK FACTOR;

ADULT; ALLELES; DERMATOMYOSITIS; FEMALE; GENOTYPE; GUATEMALA; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN GM ALLOTYPES; IMMUNOGLOBULIN JOINING REGION; INDIANS, CENTRAL AMERICAN; MALE; MEXICO; MYOSITIS; PHENOTYPE; RISK FACTORS; UNITED STATES;

EID: 0036063074     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10358     Document Type: Article

References (42)

1. Genetic background and environment contribute synergistically to the onset of autoimmune diseases
2. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions
3. Invited anniversary review: HLA associated diseases
4. Immunogenetic markers as probes for polymorphism, gene regulation and gene transfer in man: The Gm system in perspective
5. The genetics revolution and the assault on rheumatoid arthritis
6. Immunogenetics in the analysis of resistance to intracellular pathogens
7. The genetics of lupus
8. Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants
9. The immunogenetics of the seronegative spondyloarthropathies
10. Inherited and noninherited risk factors in rheumatoid arthritis
11. The role of genetic factors in autoimmune disease: Implications for environmental research
12. Polymyositis, dermatomyositis and related conditions
13. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
14. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies
15. Familial autoimmunity and the idiopathic inflammatory myopathies
16. Noninfectious environmental agents associated with myopathies
17. Update on the genetics of the idiopathic inflammatory myopathies
18. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis
19. Immunogenetic studies in families of children with juvenile dermatomyositis
20. TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications
21. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies
22. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
23. Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
24. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours
25. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: A tale of two loci
26. A new rapid method for genetic typing of human immunoglobulins
27. Cytokines as genetic modifying factors in immune and inflammatory diseases
28. A simple sequentially rejective multiple test procedure
29. Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children
30. Clinical significance of specific autoantibodies in juvenile dermatomyositis
31. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DRβ chain
32. Latitudinal gradients in the relative prevalence of dermatomyositis and its associated autoantibody, anti-Mi-2, in idiopathic inflammatory myopathy
33. The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient
34. Association of HLA class I and class II alleles with myositis in Japanese patients
35. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies
36. Prevalence of sporadic inclusion body myositis in Western Australia
37. Distinct genetic and immunologic features in patients with onset of IDDM before and after age 40
38. Juvenile rheumatoid arthritis as a complex genetic trait
39. Immunoglobulin Gm and Km allotypes and vaccine immunity
40. Infectious agents associated with myopathies